Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients. - Wikidata - wikimedia - TriplyDB

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.

http://www.wikidata.org/entity/Q37492906

about

Characterization of T-cell subpopulations in patients with chronic rhinosinusitis with nasal polyposis.Impact and Modulations of Peripheral and Edaphic B Cell Subpopulations in Chronic Rhinosinusitis With Nasal Polyposis.Tissue-resident memory T cells play a key role in the efficacy of cancer vaccines.Niches for the Long-Term Maintenance of Tissue-Resident Memory T Cells.Resident memory T cells, critical components in tumor immunology Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma Tissue-Resident Lymphocytes Across Innate and Adaptive Lineages Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy The Emerging Role of CD8 Tissue Resident Memory T (T) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin Tissue-Specific Roles of NKT Cells in Tumor Immunity

P2860

Q47120377-43A58327-6577-477A-8EC6-95CC5FD6E73B Q50158318-C1FE59E2-A781-4B12-98A2-3F99F78A034E Q50549818-D5EFBFB2-CD13-477C-A181-F4037748CDD8 Q55080099-163077A0-0110-48B1-BAB6-75FD9A112AA5 Q56889211-15BD9EE4-F85E-407B-96CE-564D88C98AED Q57135085-5DBB1387-B9AA-449F-A09C-EB7B545EDD34 Q57300016-559BFD29-BCFD-4662-A1B3-69861A32D03B Q58750149-AF23DF1B-E5DF-4590-A5DA-148CF1327A84 Q58777559-287EEDA0-7D95-4170-B736-DCC1742AC4F3 Q58777562-9D760DEA-DB45-4B66-BF5B-9A0A373BD3D8

P2860

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.

http://www.wikidata.org/entity/Q37492906

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Very Late Antigen-1 Marks Func ...... Survival of Melanoma Patients.

@en

Very Late Antigen-1 Marks Func ...... Survival of Melanoma Patients.

@nl

type

label

Very Late Antigen-1 Marks Func ...... Survival of Melanoma Patients.

@en

Very Late Antigen-1 Marks Func ...... Survival of Melanoma Patients.

@nl

prefLabel

Very Late Antigen-1 Marks Func ...... Survival of Melanoma Patients.

@en

Very Late Antigen-1 Marks Func ...... Survival of Melanoma Patients.

@nl

P1433

Q37492906-690F6262-92DB-49B6-A498-D7741D4CCFC2

P1476

Q37492906-46526E1C-F755-4F05-8C96-6F8CEC9A67D3

P2093

Q37492906-0BDADC49-2A71-419B-99F7-A5C026FD8527

Q37492906-2AF12EFF-2798-4EB1-A364-E2FB891CE11F

Q37492906-50CF97E0-B838-4366-8E5D-3248F3078FC4

Q37492906-8CB9CF5B-AA0A-4BB9-A8BF-D106CE92BAC3

Q37492906-A775BDED-E627-4BFB-82D5-8F052456372F

Q37492906-EE95A99C-FC45-4F80-9C93-B9EAF65ACF82

P2860

Q37492906-0CB46764-64EF-4CF4-BA04-7E76FEFBEB30

Q37492906-0CD03D87-4F4D-4DC0-A49C-E039FFD3FCCE

Q37492906-137950F5-2BBA-4F0B-96A7-D59F98908268

Q37492906-1775D123-93A0-4E17-B66F-125EA1A22F45

Q37492906-185F8A0E-EC51-47FD-BDA6-F2F79DCB7EBD

Q37492906-2206336D-B563-4F02-A8A0-680AF13F7E40

Q37492906-27EB648F-15C3-454F-82A4-FAC25F41B887

Q37492906-2F944483-8F9C-4669-AD9C-6D809D0A9B6F

Q37492906-3137966B-8EBD-4981-8E25-20E117E7C3FD

Q37492906-35FDB121-AC4D-46CE-8CC9-8669029360C5

P304

Q37492906-D534D162-D7AC-4719-88D8-31064234A10A

P31

Q37492906-4F5DDC27-AD65-49AB-A84D-7B71ED2C649D

P356

Q37492906-F5FF9179-762E-4761-98F0-12A8245BE5CD

P478

Q37492906-A472F3C2-8137-4FBE-B657-0F1091726BA9

P50

Q37492906-6A12F678-5E8A-4EDD-969B-F1141C3EC924

Q37492906-882140EE-BE08-4AA6-8694-FE40E2765F0A

Q37492906-AA93B1D7-262D-4EEC-87EB-731F8C4D3A6A

P577

Q37492906-1590F3CC-7524-480F-B12A-819990488D63

P698

Q37492906-7FDDC4CB-2874-4D55-8171-91C673C4FD52

P932

Q37492906-5C35174D-E50E-4D73-A657-A30AB2C3A9DD

P356

FIMMU.2016.00573

P1433

Frontiers in Immunology

P1476

Very Late Antigen-1 Marks Func ...... Survival of Melanoma Patients.

@en

P2093

Alena Donda

http://www.w3.org/2001/XMLSchema#string

Daniel E Speiser

http://www.w3.org/2001/XMLSchema#string

Laurène Cagnon

http://www.w3.org/2001/XMLSchema#string

Pedro Romero

http://www.w3.org/2001/XMLSchema#string

Petra Baumgaertner

http://www.w3.org/2001/XMLSchema#string

Timothy Murray

http://www.w3.org/2001/XMLSchema#string

P2860

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Immune Checkpoint Blockade in Cancer Therapy

TGFβ signalling in context

The immune contexture in human tumours: impact on clinical outcome

T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease.

Sensing and alarm function of resident memory CD8⁺ T cells.

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors

P304

573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2016.00573

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Grégory Verdeil

Silvia A Fuertes Marraco

P577

2016-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28018343

http://www.w3.org/2001/XMLSchema#string

P932

5150229

http://www.w3.org/2001/XMLSchema#string